The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Protease-Activated Receptors in Cardiovascular Diseases
Abstract
Thrombosis associated with the pathophysiological activation of platelets and vascular cells has brought thrombin and its receptors to the forefront of cardiovascular medicine. Thrombin signaling through the protease-activated receptors (PARs) has been shown to influence a wide range of physiological responses including platelet activation, intimal hyperplasia, inflammation, and maintenance of vascular tone and barrier function. The thrombin receptors PAR1 and PAR4 can be effectively targeted in animals in which acute or prolonged exposure to thrombin leads to thrombosis and/or restenosis. In the present study, we describe the molecular and pharmacological basis of small-molecule inhibitors that target PAR1. In addition, we discuss a new class of cell-penetrating inhibitors, termed pepducins, that provide insight into previously unidentified roles of PAR1 and PAR4 in protease signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,589
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., & Coughlin, S. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6042 · Cited by 841
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Self-citationActivation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., & Ruf, W. (2002) · Science · doi:10.1126/science.1071699 · Cited by 831
Cloning and characterization of human protease-activated receptor 4
Xu, W.-F., Andersen, H., Whitmore, T. E., Presnell, S. R., Yee, D. P., Ching, A., Gilbert, T., Davie, E. W., & Foster, D. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6642 · Cited by 817
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
Camerer, E., Huang, W., & Coughlin, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5255 · Cited by 675
Sukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657
Defective platelet activation in Gαq-deficient mice
Offermanns, S., Toombs, C. F., Hu, Y.-H., & Simon, M. I. (1997) · Nature · doi:10.1038/38284 · Cited by 561
PAR3 is a cofactor for PAR4 activation by thrombin
Nakanishi-Matsui, M., Zheng, Y.-W., Sulciner, D. J., Weiss, E. J., Ludeman, M. J., & Coughlin, S. R. (2000) · Nature · doi:10.1038/35007085 · Cited by 557
Domains specifying thrombin–receptor interaction
Vu, T.-K. H., Wheaton, V. I., Hung, D. T., Charo, I., & Coughlin, S. R. (1991) · Nature · doi:10.1038/353674a0 · Cited by 552
Garcia, J. G. N., Davis, H. W., & Patterson, C. E. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041630311 · Cited by 547
Role of thrombin signalling in platelets in haemostasis and thrombosis
Sambrano, G. R., Weiss, E. J., Zheng, Y.-W., Huang, W., & Coughlin, S. R. (2001) · Nature · doi:10.1038/35092573 · Cited by 518
McNamara, C. A., Sarembock, I. J., Gimple, L. W., Fenton, J. W., Coughlin, S. R., & Owens, G. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116206 · Cited by 499
Feistritzer, C., & Riewald, M. (2005) · Blood · doi:10.1182/blood-2004-10-3985 · Cited by 475
Hattori, R., Hamilton, K. K., Fugate, R. D., McEver, R. P., & Sims, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83104-0 · Cited by 451
Scientific and therapeutic advances in antiplatelet therapy
Bhatt, D. L., & Topol, E. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd985 · Cited by 407
Protease-activated receptors in inflammation, neuronal signaling and pain
Vergnolle, N., Wallace, J. L., Bunnett, N. W., & Hollenberg, M. D. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01634-5 · Cited by 369
Covic, L., Gresser, A. L., Talavera, J., Swift, S., & Kuliopulos, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022460899 · Cited by 314
Self-citationThrombin receptor expression in normal and atherosclerotic human arteries.
Nelken, N. A., Soifer, S. J., O'Keefe, J., Vu, T. K., Charo, I. F., & Coughlin, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116031 · Cited by 314
André, P., Denis, C. V., Ware, J., Saffaripour, S., Hynes, R. O., Ruggeri, Z. M., & Wagner, D. D. (2000) · Blood · doi:10.1182/blood.v96.10.3322 · Cited by 308
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor
Riewald, M., & Ruf, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141126698 · Cited by 306
Biphasic Kinetics of Activation and Signaling for PAR1 and PAR4 Thrombin Receptors in Platelets
Covic, L., Gresser, A. L., & Kuliopulos, A. (2000) · Biochemistry · doi:10.1021/bi9927078 · Cited by 306
Self-citationPepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
Covic, L., Misra, M., Badar, J., Singh, C., & Kuliopulos, A. (2002) · Nature Medicine · doi:10.1038/nm760 · Cited by 275
Self-citationPlatelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial
Ault, K. A., Cannon, C. P., Mitchell, J., McCahan, J., Tracy, R. P., Novotny, W. F., Reimann, J. D., & Braunwald, E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00635-4 · Cited by 249
Binding of Thrombin to Glycoprotein Ib Accelerates the Hydrolysis of Par-1 on Intact Platelets
De Candia, E., Hall, S. W., Rutella, S., Landolfi, R., Andrews, R. K., & De Cristofaro, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008160200 · Cited by 233
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
Leger, A. J., Jacques, S. L., Badar, J., Kaneider, N. C., Derian, C. K., Andrade-Gordon, P., Covic, L., & Kuliopulos, A. (2006) · Circulation · doi:10.1161/circulationaha.105.587758 · Cited by 218
Self-citationSpecificity of the thrombin receptor for agonist peptide is defined by its extracellular surface
Gerszten, R. E., Chen, J., Ishli, M., Ishil, K., Wang, L., Nanevicz, T., Turck, C. W., Vu, T.-K. H., & Coughlin, S. R. (1994) · Nature · doi:10.1038/368648a0 · Cited by 208
Tissue Factor–Factor VIIa Signaling
Rao, L. V. M., & Pendurthi, U. R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151624.45775.13 · Cited by 194
Thrombin and Phenotypic Modulation of the Endothelium
Minami, T., Sugiyama, A., Wu, S.-Q., Abid, R., Kodama, T., & Aird, W. C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000099880.09014.7d · Cited by 187
Andrade-Gordon, P., Maryanoff, B. E., Derian, C. K., Zhang, H.-C., Addo, M. F., Darrow, A. L., Eckardt, A. J., Hoekstra, W. J., McComsey, D. F., Oksenberg, D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12257 · Cited by 185
Handbook of Cell-Penetrating Peptides
(2006) · CRC Press eBooks · doi:10.1201/9781420006087 · Cited by 185
Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells
Kataoka, H., Hamilton, J. R., McKemy, D. D., Camerer, E., Zheng, Y.-W., Cheng, A., Griffin, C., & Coughlin, S. R. (2003) · Blood · doi:10.1182/blood-2003-04-1130 · Cited by 184
Damiano, B. P., Cheung, W.-M., Santulli, R. J., Fung-Leung, W.-P., Ngo, K., Ye, R. D., Darrow, A. L., Derian, C. K., de Garavilla, L., & Andrade-Gordon, P. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38005-x · Cited by 182
Mirza, H., Yatsula, V, & Bahou, W. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118597 · Cited by 181
Signaling Properties and Functions of Two Distinct Cardiomyocyte Protease-Activated Receptors
Sabri, A., Muske, G., Zhang, H., Pak, E., Darrow, A., Andrade-Gordon, P., & Steinberg, S. F. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1054 · Cited by 166
Activated protein C variants with normal cytoprotective but reduced anticoagulant activity
Mosnier, L. O., Gale, A. J., Yegneswaran, S., & Griffin, J. H. (2004) · Blood · doi:10.1182/blood-2004-01-0110 · Cited by 166
Biological Consequences of Thrombin Receptor Deficiency in Mice
Darrow, A. L., Fung-Leung, W.-P., Ye, R. D., Santulli, R. J., Cheung, W.-M., Derian, C. K., Burns, C. L., Damiano, B. P., Zhou, L., Keenan, C. M., et al. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650676 · Cited by 163
Derian, C. K., Damiano, B. P., Addo, M. F., Darrow, A. L., D’Andrea, M. R., Nedelman, M., Zhang, H.-C., Maryanoff, B. E., & Andrade-Gordon, P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042663 · Cited by 161
Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells
Camerer, E., Kataoka, H., Kahn, M. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108555200 · Cited by 155
Vouret‐Craviari, V., Bourcier, C., Boulter, E., & Obberghen‐Schilling, E. V. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2475 · Cited by 151
Development of Potent Thrombin Receptor Antagonist Peptides
Bernatowicz, M. S., Klimas, C. E., Hartl, K. S., Peluso, M., Allegretto, N. J., & Seiler, S. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960455s · Cited by 144
Reversing systemic inflammatory response syndrome with chemokine receptor pepducins
Kaneider, N. C., Agarwal, A., Leger, A. J., & Kuliopulos, A. (2005) · Nature Medicine · doi:10.1038/nm1245 · Cited by 137
Self-citationMechanisms of Thrombin Receptor Agonist Specificity
Nanevicz, T., Ishii, M., Wang, L., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21619 · Cited by 123
The Human Proteinase-activated Receptor-3 (PAR-3) Gene
Schmidt, V. A., Nierman, W. C., Maglott, D. R., Cupit, L. D., Moskowitz, K. A., Wainer, J. A., & Bahou, W. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15061 · Cited by 117
Garcia, J. G. N., Patterson, C. E., Bahler, C., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560313 · Cited by 116
Hollenberg, M. D., Saifeddine, M., Sandhu, S., Houle, S., & Vergnolle, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705946 · Cited by 116
Andrade‐Gordon, P., Derian, C. K., Maryanoff, B. E., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29348-4 · Cited by 112
Jacques, S. L., & Kuliopulos, A. (2003) · Biochemical Journal · doi:10.1042/bj20030954 · Cited by 101
Self-citationMorgan, A. R., Rerkasem, K., Gallagher, P. J., Zhang, B., Morris, G. E., Calder, P. C., Grimble, R. F., Eriksson, P. O., McPheat, W. L., Shearman, C. P., et al. (2004) · Stroke · doi:10.1161/01.str.0000126822.01756.99 · Cited by 99
Houle, S., Papez, M. D., Ferazzini, M., Hollenberg, M. D., & Vergnolle, N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706371 · Cited by 97
Keuren, J. F. W., Wielders, S. J. H., Ulrichts, H., Hackeng, T. M., Heemskerk, J. W. M., Deckmyn, H., Bevers, E. M., & Lindhout, T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000167526.31611.f6 · Cited by 87
Plasmin-induced Migration Requires Signaling through Protease-activated Receptor 1 and Integrin α9β1
Majumdar, M., Tarui, T., Shi, B., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401372200 · Cited by 80
Zhang, H., Derian, C. K., Andrade‐Gordon, P., Hoekstra, W. J., McComsey, D. F., White, K. B., Poulter, B. L., Addo, M. F., Cheung, W.-M., Damiano, B. P., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000506s · Cited by 75
Cheung, W.-M., Andrade‐Gordon, P., Derian, C. K., & Damiano, B. P. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-1-16 · Cited by 69
Ishii, K., Gerszten, R. E., Zheng, Y. W., Welsh, J. B., Turck, C. W., & Coughlin, S. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16435 · Cited by 64
Ku, D. D., & Dai, J. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199711000-00016 · Cited by 52
Fujiwara, M., Jin, E., Ghazizadeh, M., & Kawanami, O. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6592.2005 · Cited by 22
Cited by
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
Morrow, D. A., Braunwald, E., Bonaca, M. P., Ameriso, S. F., Dalby, A. J., Fish, M. P., Fox, K. A. A., Lipka, L. J., Liu, X., Nicolau, J. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200933 · Cited by 948
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication
Breitling, L. P., Yang, R., Korn, B., Burwinkel, B., & Brenner, H. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.003 · Cited by 640
Jennings, L. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0192 · Cited by 436
Endothelial cells and coagulation
Neubauer, K., & Zieger, B. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03471-2 · Cited by 351
Serpins in thrombosis, hemostasis and fibrinolysis
RAU, J. C., BEAULIEU, L. M., HUNTINGTON, J. A., & CHURCH, F. C. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02516.x · Cited by 347
Metadata
- Authors
- Leger, A. J., Covic, L., & Kuliopulos, A.
- Venue
- Circulation
- Published
- 2006-09-05
- Volume
- 114
- Issue
- 10
- Pages
- 1070-1077
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2163946154
- Cited by
- 289
- References
- 60
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.